Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Adolescent depression: controlled desipramine treatment and atypical features.

Klein RG, Mannuzza S, Koplewicz HS, Tancer NK, Shah M, Liang V, Davies M.

Depress Anxiety. 1998;7(1):15-31.

PMID:
9592629
2.

Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.

McDowell D, Nunes EV, Seracini AM, Rothenberg J, Vosburg SK, Ma GJ, Petkova E.

Drug Alcohol Depend. 2005 Nov 1;80(2):209-21.

PMID:
15913920
3.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
4.
5.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
6.

Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.

Fawcett J, Edwards JH, Kravitz HM, Jeffriess H.

J Clin Psychopharmacol. 1987 Oct;7(5):295-310.

PMID:
3316312
7.

Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.

Quitkin FM, Stewart JW, McGrath PJ, Tricamo E, Rabkin JG, Ocepek-Welikson K, Nunes E, Harrison W, Klein DF.

Br J Psychiatry Suppl. 1993 Sep;(21):30-4.

PMID:
8217065
8.

Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.

Hoehn-Saric R, Ninan P, Black DW, Stahl S, Greist JH, Lydiard B, McElroy S, Zajecka J, Chapman D, Clary C, Harrison W.

Arch Gen Psychiatry. 2000 Jan;57(1):76-82.

PMID:
10632236
9.

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial.

Kutcher S, Boulos C, Ward B, Marton P, Simeon J, Ferguson HB, Szalai J, Katic M, Roberts N, Dubois C, et al.

J Am Acad Child Adolesc Psychiatry. 1994 Jun;33(5):686-94.

PMID:
8056732
10.

Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.

Cappiello A, McDougle CJ, Delgado PL, Malison RT, Jatlow P, Charney DS, Heninger GR, Price LH.

Int Clin Psychopharmacol. 1998 Sep;13(5):191-8.

PMID:
9817623
11.

Pharmacotherapy response and diagnostic validity in atypical depression.

Sotsky SM, Simmens SJ.

J Affect Disord. 1999 Aug;54(3):237-47.

PMID:
10467966
12.

Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.

Fava M, Alpert J, Nierenberg A, Lagomasino I, Sonawalla S, Tedlow J, Worthington J, Baer L, Rosenbaum JF.

J Clin Psychopharmacol. 2002 Aug;22(4):379-87.

PMID:
12172337
13.

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.

Freeman EW, Rickels K, Sondheimer SJ, Polansky M.

Arch Gen Psychiatry. 1999 Oct;56(10):932-9.

PMID:
10530636
14.

A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving.

Docherty JP, Sack DA, Roffman M, Finch M, Komorowski JR.

J Psychiatr Pract. 2005 Sep;11(5):302-14.

PMID:
16184071
15.

Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.

Nelson JC, Mazure CM, Jatlow PI, Bowers MB Jr, Price LH.

Biol Psychiatry. 2004 Feb 1;55(3):296-300.

PMID:
14744472
16.

A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression.

Kye CH, Waterman GS, Ryan ND, Birmaher B, Williamson DE, Iyengar S, Dachille S.

J Am Acad Child Adolesc Psychiatry. 1996 Sep;35(9):1139-44.

PMID:
8824057
18.
19.

Response to desipramine treatment in adolescent major depression.

Boulos C, Kutcher S, Marton P, Simeon J, Ferguson B, Roberts N.

Psychopharmacol Bull. 1991;27(1):59-65.

PMID:
1862207
20.

A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.

Mulsant BH, Sweet RA, Rosen J, Pollock BG, Zubenko GS, Flynn T, Begley AE, Mazumdar S, Reynolds CF 3rd.

J Clin Psychiatry. 2001 Aug;62(8):597-604.

PMID:
11561930

Supplemental Content

Support Center